Total Payments
$7,822
2024 Payments
$51.93
Companies
32
Transactions
212
Medicare Patients
624
Medicare Billing
$170,979
Payment Breakdown by Category
Other$3,800 (48.6%)
Food & Beverage$2,872 (36.7%)
Travel$1,065 (13.6%)
Education$85.09 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,800 | 3 | 48.6% |
| Food and Beverage | $2,872 | 185 | 36.7% |
| Travel and Lodging | $1,065 | 7 | 13.6% |
| Education | $85.09 | 17 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $5,319 | 20 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $328.64 | 30 | $0 (2018) |
| Novo Nordisk Inc | $278.62 | 18 | $0 (2019) |
| GlaxoSmithKline, LLC. | $205.57 | 17 | $0 (2019) |
| Amgen Inc. | $197.79 | 11 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $184.63 | 24 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $163.25 | 7 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $125.37 | 12 | $0 (2018) |
| Lilly USA, LLC | $123.90 | 9 | $0 (2019) |
| Orexo US, Inc. | $115.71 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.93 | 1 | Braeburn Inc. ($51.93) |
| 2022 | $89.64 | 6 | Indivior Inc. ($64.59) |
| 2021 | $13.04 | 1 | Pear Therapeutics (US), Inc. ($13.04) |
| 2020 | $24.78 | 2 | Orexo US, Inc. ($24.78) |
| 2019 | $5,296 | 23 | Indivior Inc. ($5,165) |
| 2018 | $1,101 | 78 | Janssen Pharmaceuticals, Inc ($172.88) |
| 2017 | $1,245 | 101 | Janssen Pharmaceuticals, Inc ($155.76) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $51.93 | General |
| Category: Opioid Use Disorder | ||||||
| 08/25/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: OUD | ||||||
| 08/11/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: OUD | ||||||
| 06/22/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.63 | General |
| 05/26/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: OUD | ||||||
| 05/17/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.42 | General |
| 03/22/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: OUD | ||||||
| 03/17/2021 | Pear Therapeutics (US), Inc. | reSET-O (Device) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: Prescription Digital Therapeutics | ||||||
| 09/22/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $11.17 | General |
| Category: Addiction Medicine | ||||||
| 06/08/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $13.61 | General |
| Category: Addiction Medicine | ||||||
| 10/22/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Addiction Medicine | ||||||
| 08/26/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Addiction Medicine | ||||||
| 07/26/2019 | Indivior Inc. | SUBLOCADE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: OUD | ||||||
| 07/10/2019 | Indivior Inc. | SUBLOCADE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: OUD | ||||||
| 06/04/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $13.80 | General |
| Category: Addiction Medicine | ||||||
| 05/31/2019 | Indivior Inc. | SUBLOCADE (Drug) | Education | In-kind items and services | $7.46 | General |
| Category: OUD | ||||||
| 05/29/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: OUD | ||||||
| 05/29/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $52.00 | General |
| Category: OUD | ||||||
| 05/29/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $32.48 | General |
| Category: OUD | ||||||
| 05/29/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: OUD | ||||||
| 05/17/2019 | Indivior Inc. | SUBLOCADE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: OUD | ||||||
| 05/04/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $275.00 | General |
| Category: OUD | ||||||
| 05/04/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $160.41 | General |
| Category: OUD | ||||||
| 05/03/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $245.37 | General |
| Category: OUD | ||||||
| 04/23/2019 | Indivior Inc. | SUBLOCADE (Drug) | Travel and Lodging | In-kind items and services | $489.37 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 134 | 593 | $62,958 | $27,622 |
| 2022 | 4 | 147 | 723 | $89,692 | $43,176 |
| 2021 | 3 | 147 | 658 | $84,407 | $44,333 |
| 2020 | 5 | 196 | 753 | $133,595 | $55,848 |
Total Patients
624
Total Services
2,727
Medicare Billing
$170,979
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 256 | $44,436 | $20,550 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 63 | $7,593 | $3,811 | 50.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 49 | 232 | $8,912 | $2,865 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 42 | $2,017 | $396.27 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 437 | $73,248 | $36,650 | 50.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 52 | 233 | $8,621 | $2,896 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 41 | $4,715 | $2,612 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,108 | $1,018 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 365 | $61,320 | $31,624 | 51.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 157 | $18,055 | $10,995 | 60.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 37 | 136 | $5,032 | $1,714 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 623 | $104,664 | $47,166 | 45.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 36 | $20,088 | $5,704 | 28.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $5,698 | $1,980 | 34.7% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 36 | 37 | $1,850 | $558.70 | 30.2% |
| 80305 | Testing for presence of drug | Office | 2020 | 24 | 35 | $1,295 | $439.50 | 33.9% |
About Dr. Bryan Negrini, MD
Dr. Bryan Negrini, MD is a Internal Medicine healthcare provider based in Aliquippa, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487670246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Negrini, MD has received a total of $7,822 in payments from pharmaceutical and medical device companies, with $51.93 received in 2024. These payments were reported across 212 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,800).
As a Medicare-enrolled provider, Negrini has provided services to 624 Medicare beneficiaries, totaling 2,727 services with total Medicare billing of $170,979. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aliquippa, PA
- Active Since 07/14/2006
- Last Updated 12/13/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487670246
Products in Payments
- SUBLOCADE (Drug) $5,302
- INVOKANA (Drug) $192.04
- Victoza (Drug) $186.36
- XARELTO (Drug) $136.60
- Prolia (Biological) $133.57
- TOUJEO (Drug) $131.60
- Zubsolv (Drug) $115.71
- TRULICITY (Drug) $101.98
- ANORO (Drug) $98.89
- SPIRIVA RESPIMAT (Drug) $85.65
- Trintellix (Drug) $82.32
- JANUVIA (Drug) $65.43
- FARXIGA (Drug) $65.29
- Myrbetriq (Drug) $54.28
- APTIOM (Drug) $53.59
- BRIXADI (Drug) $51.93
- Ozempic (Drug) $48.24
- BREO (Drug) $46.17
- JARDIANCE (Drug) $45.10
- Repatha (Biological) $41.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aliquippa
Dr. Ashwini Gandhe, M.d, M.D
Internal Medicine — Payments: $13,598
Internal Medicine $13,598
Dr. Randy Shemer, D.o, D.O
Internal Medicine — Payments: $12,227
Internal Medicine $12,227
Hannah Harrison, Pa-C, PA-C
Internal Medicine — Payments: $762.41
Internal Medicine $762.41
Amar Singh, Md, MD
Internal Medicine — Payments: $393.08
Internal Medicine $393.08
Corinne Conte, M.d, M.D
Internal Medicine — Payments: $377.97
Internal Medicine $377.97
Dr. Pamela Dumpe, M.d, M.D
Internal Medicine
Internal Medicine